PlGF–MMP9-engineered iPS cells supported on a PEG–fibrinogen hydrogel scaffold possess an enhanced capacity to repair damaged myocardium

Cell-based regenerative therapies are significantly improved by engineering allografts to express factors that increase vascularization and engraftment, such as placental growth factor (PlGF) and matrix metalloproteinase 9 (MMP9). Moreover, the seeding of therapeutic cells onto a suitable scaffold i...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bearzi, C, Gargioli, C, Baci, D, Fortunato, O, Shapira-Schweitzer, K, Kossover, O, Latronico, M V G, Seliktar, D, Condorelli, G, Rizzi, R
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3944231/
https://ncbi.nlm.nih.gov/pubmed/24525729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2014.12
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares